JPMorgan on Protagonist Therapeutics (PTGX): 'The Kids Are Almost Out of the House'
Tweet Send to a Friend
JPMorgan analyst Brian Cheng reiterated an Overweight rating and $93.00 price target on Protagonist Therapeutics (NASDAQ: PTGX).The analyst comments "With ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
